Drugs / C1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01303328 | Mar 2011 → Feb 2013 | cervical intraepithelial neoplasia, uterine cervix neoplasm | Mithra Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01303328 ↗ |
| Route | Other | “administered directly on cervix” NCT01303328 ↗ |